FA
MREO
Forefront Analytics’s Mereo BioPharma MREO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.9K | Sell |
19,138
-28,492
| -60% | -$77.2K | 0.06% | 41 |
|
|
2025
Q1 | $107K | Buy |
47,630
+12,877
| +37% | +$29K | 0.12% | 38 |
|
|
2024
Q4 | $122K | Buy |
34,753
+953
| +3% | +$3.34K | 0.06% | 56 |
|
|
2024
Q3 | $139K | Sell |
33,800
-2,431
| -7% | -$9.99K | 0.07% | 58 |
|
|
2024
Q2 | $130K | Sell |
36,231
-7,586
| -17% | -$27.3K | 0.06% | 61 |
|
|
2024
Q1 | $145K | Buy |
43,817
+7,693
| +21% | +$25.4K | 0.07% | 56 |
|
|
2023
Q4 | $83.4K | Sell |
36,124
-29,525
| -45% | -$68.2K | 0.04% | 62 |
|
|
2023
Q3 | $84.7K | Sell |
65,649
-17,100
| -21% | -$22.1K | 0.05% | 56 |
|
|
2023
Q2 | $109K | Sell |
82,749
-951
| -1% | -$1.26K | 0.06% | 55 |
|
|
2023
Q1 | $59.2K | Buy |
83,700
+10,200
| +14% | +$7.21K | 0.03% | 67 |
|
|
2022
Q4 | $55.1K | Sell |
73,500
-39,300
| -35% | -$29.5K | 0.03% | 67 |
|
|
2022
Q3 | $96K | Buy |
112,800
+36,950
| +49% | +$31.4K | 0.05% | 52 |
|
|
2022
Q2 | $83K | Buy |
+75,850
| New | +$83K | 0.04% | 53 |
|